ATOMMAP
LIVE

Serial Number

98367135

Owner

Atommap Corporation

Attorney

John Paul Oleksiuk

First Use Date

Feb 20, 2023

Filing Date

Jan 19, 2024

Add to watchlist:

No watchlists yet
View on USPTO

ATOMMAP Trademark

Serial Number: 98367135 • Registration: 8223977

ATOMMAP is a trademark filed by Atommap Corporation on January 19, 2024. The trademark is classified under Class 42 (Computer & Scientific). The application is currently registered and active.

Owner Contact Info

Atommap Corporation (4 trademarks)

1299 PENNSYLVANIA AVENUE, NW SUITE 700
Washington, DC 20004

Entity Type: 03

Trademark Details

Filing Date

January 19, 2024

Registration Date

April 21, 2026

First Use Anywhere

February 20, 2023

First Use in Commerce

February 20, 2023

Published for Opposition

September 17, 2024

Goods & Services

Research and development in the field of computational biology, bioinformatics, and genomics; Drug discovery services; providing medical and scientific research information in the field of pharmaceuticals and clinical trials; pharmaceutical, medical, scientific, biotechnology, and biopharmaceutical research and development; technical scientific consultation and product development for others in the field of biotechnology and immunology; development of pharmaceuticals; research and development of pharmaceutical preparations and substances for use in clinical trials; scientific and technological services, namely, research and design in the field of computational chemistry, machine learning and artificial intelligence for use in chemistry, biology, physics, biochemistry, chemical engineering, and computer science, and design and optimization of molecules, materials, and drugs; chemistry services, namely, laboratory research in the fields of chemistry and design of new chemistry; chemistry services in the nature of drug, and molecular discovery services, and product development services; chemical research and chemistry consultation in the field of drug and molecular development; industrial analysis and research services being scientific research in the field of drug, materials, and molecular development; technical data analysis services being technology advisory services relating to computer programs for use in chemistry, biology, physics, biochemistry, chemical engineering, computer science, and the discovery of new molecules, materials, drugs, and machine learning techniques; computer programming in the fields of molecular, materials, and drug development; computer consultancy services being computer software consultation in the field of drug, materials, and molecular development; computer software consultation services, namely, assistance and consulting in connection with the development of computer applications, databases and systems for use in the field of drug, materials, and molecular development; consulting services in the design and implementation of computer-based information systems for business, namely, provision of online information relating to computer hardware and software design in the field of drug, materials, and molecular development; creation, maintenance, hosting, and design of websites in the field of drug, materials, and molecular development; provision of online non-downloadable software for simulations for drug, materials, and molecular discovery; provision of online non-downloadable software for use in optimizing drug, materials, and molecular discovery; creating website based indexes of information for others using information technology for use in the field of drug, materials, and molecular development; computer graphics design services, namely, realization of computer graphics and digital imaging for use in the field of drug, materials, and molecular development; scientific research in connection with computerized automation of technical processes for use in the field of drug, materials, and molecular development; cloud-based computing featuring software for optimizing the development of new molecules and designing and discovering molecules, drugs, battery materials, and other molecular products

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Apr 21, 2026 NRCC
REGISTERED-PRINCIPAL REGISTER
Apr 21, 2026 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Mar 30, 2026 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Mar 30, 2026 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Nov 12, 2025 SUPC
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Nov 12, 2025 AITU
USE AMENDMENT FILED
May 29, 2025 IUAF
TEAS STATEMENT OF USE RECEIVED
May 29, 2025 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 8, 2025 EXRA
SOU EXTENSION 1 GRANTED
May 8, 2025 EX1G
SOU EXTENSION 1 FILED
May 8, 2025 EXT1
SOU TEAS EXTENSION RECEIVED
May 7, 2025 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 12, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 17, 2024 NPUB
PUBLISHED FOR OPPOSITION
Sep 17, 2024 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 28, 2024 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 14, 2024 CNSA
ASSIGNED TO EXAMINER
Aug 14, 2024 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 7, 2024 NWOS
NEW APPLICATION ENTERED
Jan 24, 2024 NWAP